Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


ResMed reported $588K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Ansell ANN:AU USD 756.8M 13M
Artivion Inc CRY:US USD 424K 6K
AtriCure ATRC:US USD 47K 0
Baxter International BAX:US USD 683M 0
Cochlear COH:AU AUD 1.28B 100K
Cooper Companies COO:US USD 5.4M 0
Dexcom DXCM:US USD 400K 0
Edwards Lifesciences EW:US USD 647.1M 800K
Estia Health EHE:AU AUD 796.42M 674K
Fisher Paykel Healthcare FPH:NZ NZD 307M 42.1M
Globus Medical GMED:US USD 100K 0
Haemonetics HAE:US USD 504K 0
Hologic HOLX:US USD 3M 0
Idexx Laboratories IDXX:US USD 15.9M 5K
Insulet PODD:US USD 100K 0
Integra LifeSciences IART:US USD 908K 3K
Intuitive Surgical ISRG:US USD 400K 0
Masimo MASI:US USD 100K 0
NuVasive NUVA:US USD 63K 0
Ramsay Health Care RHC:AU AUD 2.2B 0
ResMed RMD:US USD 588K 0
Sigma Healthcare Ltd SIG:AU AUD 1.23B 4.08M
Sonic Healthcare SHL:AU AUD 3.76B 106.79M
Teleflex TFX:US USD 47.97M 18K